The global metabolomics biomarker market size was accounted at USD 188 million in 2018 and expected to grow at a CAGR of 12.2% during the forecast period. Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms. Collectively, these small molecules and their interactions within a biological system are known as the metabolome. Metabolites have been used as biomarkers for decades. The oldest application of metabolomics involves identifying presence of sugar in urine for diabetes. Study of metabolites results in a growing number of biomarkers that is transforming the healthcare and life science industry. Metabolomics is a powerful tool as the metabolites and their concentrations reflects the primary biochemical activity and state of tissues/cells. Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly contribute in the market growth during forecast period.

Request a free sample of our report on Metabolomics Biomarker Market : https://www.omrglobal.com/request-sample/metabolomics-biomarker-market

Other factors such as ongoing research on metabolomics biomarker and extensive application of metabolomics biomarker such as in colorectal cancer detection are also expected to drive the market growth. Further, increasing pharmaceutical and biotech R&D expenditure is also contributing in the market. Limitations in biological and experimental measurements, high capital cost of tools and instruments and limited well-qualified researchers are limiting the growth of the market. However, increasing demand of drug development and personalized medicine and huge investments in metabolomics biomarker market research is creating enormous opportunities for the market.

A full report of Metabolomics Biomarker Market is available at : https://www.omrglobal.com/industry-reports/metabolomics-biomarker-market

Global Metabolomics Biomarker Market Segmentation

By application

Toxicological studies

Drug testing

Cancer

Cardiovascular disorders

Neurological disorders

Inborn errors of metabolism

Other

By technologies

Gas chromatography (gc)

High-performance liquid chromatography (hplc)

Ultra-performance liquid chromatography (uplc)

Nuclear magnetic resonance (nmr)

Mass spectrometry

Surface based mass analysis

Bioinformatics

Other

By end users

Hospitals

Diagnostic labs

Research centres

Competitive landscape

Key company analysis

Key strategy analysis

Regional analysis

North american

United states

Canada

Europe

U.k

Germany

Italy

Spain

France

Roe

Asia pacific

India

China

Japan

Roapac

Rest of the world

Company profiles

Ab sciex

Bg medicine inc.

Biocrates life sciences ag

Biomark diagnostics inc.

Chenomx inc.

Creative proteomics.

Evotec a.g.

Human metabolome technologies america, inc.

Merck kgaa,

Metabolomic diagnostics ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/metabolomics-biomarker-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404